Showing results (91-100 of 227) with videos related to
Sort By:
Pageof 23
Cancer Treatment Reports|February 1, 1983
Repeated femoral vein cannulation for administration of chemotherapeutic agentsB D Nidus, J L Speyer, J Bottino, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
4'Epidoxorubicin (epirubicin): activity in hepatocellular carcinomaH S Hochster, M D Green, J Speyer, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
m-AMSA: a new anticancer agentM Rozencweig, D D Von Hoff, S S Legha, et al.Cancer Chemotherapy and Pharmacology|March 11, 1999
Expression of GADD153 in tumor cells and stromal cells from xenografted tumors in nude mice treated with cisplatin: correlations with cisplatin-DNA adductsA Johnsson, C Strand, G LosAmerican Journal of Clinical Oncology|December 1, 1984
Phase II trial of cyclophosphamide and cis-platinum for non-small cell bronchogenic carcinomaA M Schmidt, R H Blum, M Clayton, et al.Cancer|July 1, 1976
De novo Kaposi's sarcoma in renal transplantation. Case report and brief reviewM A Hardy, P Goldfarb, S Levine, et al.Gynecologic Oncology|August 6, 2000
Phase II study of liposomal doxorubicin in advanced gynecologic cancersV P Israel, A A Garcia, L Roman, et al.Journal of Neuro-Oncology|August 10, 2000
Phase II study of combination taxol and estramustine phosphate in the treatment of recurrent glioblastoma multiformeM A Rosenthal, M L Gruber, J Glass, et al.Cancer Treatment Reports|March 1, 1984
Phase II trial of PALA in lymphoma: an Eastern Cooperative Oncology Group studyF M Muggia, A A Tsiatis, M J O'Connell, et al.Environmental Health Perspectives|November 1, 1992
Cisplatin-DNA damage and repair in peripheral blood leukocytes in vivo and in vitroM Dabholkar, L Bradshaw, R J Parker, et al.Pageof 23